Faculty Opinions recommendation of Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).
2016 ◽
Vol 52
◽
pp. 201-208
◽
Keyword(s):
2012 ◽
Vol 48
(3)
◽
pp. 311-323
◽
Keyword(s):
2007 ◽
Vol 6
(2)
◽
pp. 238
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 9096-9096
◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. 3553-3553
Keyword(s):